Abstract |
We have evaluated the effects of the carbon monoxide-releasing molecule CORM-A1 [Na(2) ( BH(3) CO(2) ); ALF421] on the development of relapsing-remitting experimental allergic encephalomyelitis (EAE) in SJL mice, an established model of multiple sclerosis (MS). The data show that the prolonged prophylactic administration of CORM-A1 improves the clinical and histopathological signs of EAE, as shown by a reduced cumulative score, shorter duration and a lower cumulative incidence of the disease as well as milder inflammatory infiltrations of the spinal cords. This study suggests that the use of CORM-A1 might represent a novel therapeutic strategy for the treatment of multiple sclerosis.
|
Authors | P Fagone, K Mangano, C Quattrocchi, R Motterlini, R Di Marco, G Magro, N Penacho, C C Romao, F Nicoletti |
Journal | Clinical and experimental immunology
(Clin Exp Immunol)
Vol. 163
Issue 3
Pg. 368-74
(Mar 2011)
ISSN: 1365-2249 [Electronic] England |
PMID | 21235533
(Publication Type: Journal Article)
|
Copyright | © 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Boranes
- Carbonates
- Myelin Proteolipid Protein
- Peptide Fragments
- myelin proteolipid protein (139-151)
- sodium boranocarbonate
- Dexamethasone
- Carbon Monoxide
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, blood, pharmacology, therapeutic use)
- Body Weight
(drug effects)
- Boranes
(pharmacokinetics, therapeutic use)
- Carbon Monoxide
(administration & dosage, blood, pharmacology, therapeutic use)
- Carbonates
(pharmacokinetics, therapeutic use)
- Dexamethasone
(pharmacology, therapeutic use)
- Encephalomyelitis, Autoimmune, Experimental
(diagnosis, immunology, pathology, prevention & control)
- Female
- Mice
- Myelin Proteolipid Protein
(immunology)
- Neutrophils
(pathology)
- Peptide Fragments
(immunology)
- Spinal Cord
(drug effects, pathology)
|